Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Anhui Medical UniversityActive in the last 2 years

Fubao Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-2874-2751; OpenAlex author ID A5101880785. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Cancer-Associated Fibroblast-Centric Risk Model Predicts Immunotherapy Resistance in Pancreatic Cancer and Reveals PLOD2 as a Key Stromal Therapeutic Target. Last author DOI 10.31083/fbl46316↗
  2. Prognostic Value of Drug Targets Predicted Using Deep Bioinformatic Analysis of m6A-Associated lncRNA-Based Pancreatic Cancer Model Characteristics and Its Tum… Last author DOI 10.3389/fgene.2022.853471↗
  3. Circular RNA ciRS-7 promotes the proliferation and metastasis of pancreatic cancer by regulating miR-7-mediated EGFR/STAT3 signaling pathway. First author DOI 10.1016/j.hbpd.2019.03.003↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pengwei Cao · 2 shared papers, 2022–2025 · strength 0.44
  2. Daoxiang Zhang · 1 shared paper, 2025 · strength 0.24
  3. Mengjie Lv · 1 shared paper, 2025 · strength 0.24
  4. Lei Liu · 1 shared paper, 2022 · strength 0.20
  5. Qiang Huang · 1 shared paper, 2019 · strength 0.10
  6. Lei Liu · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.